loader
Please Wait
Applying Filters...

Evonik Evonik

X

List of Certificates of Suitability (CEPs) for r0_cep_2017_098___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 APOTEX PHARMACHEM INDIA PVT. LTD Bangalore IN (1)

filter

01 Olmesartan medoxomil (1)

filter

01 Canada (1)

filter

01 Withdrawn by Holder (1)

URL Supplier Web Content
R0-CEP 2017-098 - Rev 01
Withdrawn by Holder
Chemical
2020-01-08
2022-01-20
2600
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R0-CEP 2017-098 - Rev 01 of Apotex Pharmachem India Pvt. Ltd Bangalore In

Looking for Certificates of Suitability (CEPs) for R0-CEP 2017-098 - Rev 01 of Apotex Pharmachem India Pvt. Ltd Bangalore In 1

20

Apotex Pharmachem India Pvt. Ltd Bangalore In, based in Canada, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their significant offerings is Olmesartan medoxomil, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2017-098 - Rev 01

This Chemical Type CEP, issued on January 08, 2020, remains in force until January 20, 2022, ensuring its reliability within the pharmaceutical industry.

Substance Number 2600 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY